IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD

BACKGROUND AND OBJECTIVES: Systemic inflammation modulates cardiovascular disease risk and functionality of HDL in the setting of CKD. Whether interventions that modify systemic inflammation can improve HDL function in CKD is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin J Am Soc Nephrol
Päätekijät: Hung, Adriana M., Tsuchida, Yohei, Nowak, Kristen L., Sarkar, Sudipa, Chonchol, Michel, Whitfield, Victoria, Salas, Natjalie, Dikalova, Anna, Yancey, Patricia G., Huang, Jiansheng, Linton, MacRae F., Ikizler, T. Alp, Kon, Valentina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Nephrology 2019
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500942/
https://ncbi.nlm.nih.gov/pubmed/31015261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04360418
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia